Life Hopes Resolution Agreement and Correction Action Plan

Resolution Agreement

I.    Recitals

  1. Parties.  The Parties to this Resolution Agreement (“Agreement”) are:

            A. The United States Department of Health and Human Services, Office for Civil Rights (“HHS”), which enforces the Federal standards that govern the privacy of individually identifiable health information (45 C.F.R. Part 160 and Subparts A and E of Part 164, the “Privacy Rule”), the Federal standards that govern the security of electronic individually identifiable health information (45 C.F.R. Part 160 and Subparts A and C of Part 164, the “Security Rule”), and the Federal standards for notification in the case of breach of unsecured protected health information (45 C.F.R. Part 160 and Subparts A and D of 45 C.F.R. Part 164, the “Breach Notification Rule”).  HHS has the authority to conduct compliance reviews and investigations of complaints alleging violations of the Privacy, Security, and Breach Notification Rules (the “HIPAA Rules”) by covered entities and business associates, and covered entities and business associates must cooperate with HHS compliance reviews and investigations. See 45 C.F.R. §§ 160.306(c), 160.308, and 160.310(b).

Life Hope Labs, LLC (“Life Hope Labs”), which meets the definition of “covered entity” under 45 C.F.R. § 160.103 and therefore is required to comply with the HIPAA Rules.

C. HHS and Life Hope Labs shall together be referred to herein as the “Parties.”

  1. Factual Background and Covered Conduct

On August 24, 2021, OCR received a complaint against Life Hope Labs from the personal representative of the patient’s estate (“Complainant”). The complaint alleged that Life Hope Labs failed to provide the Complainant with a copy of the patient’s (“Decedent”) medical records in response to the Complainant’s July 2021 access requests. Life Hope Labs did not send the Complainant the requested records until February 16, 2022, 225 days after the Complainant’s initial access request. OCR’s investigation indicated that the following conduct occurred (“Covered Conduct”):
Life Hope Labs did not provide the Complainant timely access to the requested protected health information of the Decedent in a designated record set. See 45 C.F.R. § 164.524.

  1. No Admission.  This Agreement is not an admission of liability by Life Hope Labs.
  2. No Concession.  This Agreement is not a concession by HHS that Life Hope Labs is not in violation of the HIPAA Rules and not liable for civil money penalties.
  3. Intention of Parties to Effect Resolution.  This Agreement is intended to resolve HHS Transaction Number: 04-21-439775 and any violations of the HIPAA Rules related to the Covered Conduct specified in paragraph I.2 of this Agreement. In consideration of the Parties’ interest in avoiding the uncertainty, burden, and expense of formal proceedings, the Parties agree to resolve this matter according to the Terms and Conditions below.

II.  Terms and Conditions

  1. Payment.  HHS has agreed to accept, andLife Hope Labs has agreed to pay HHS, the amount of $16,500 (“Resolution Amount”).  Life Hope Labs agrees to pay the Resolution Amount on the Effective Date of this Agreement as defined in paragraph II.14 pursuant to written instructions to be provided by HHS.
  2. Corrective Action Plan.  Life Hope Labs has entered into and agrees to comply with the Corrective Action Plan (“CAP”), attached as Appendix A, which is incorporated into this Agreement by reference.  If Life Hope Labs breaches the CAP, and fails to cure the breach as set forth in the CAP, then Life Hope Labs will be in breach of this Agreement and HHS will not be subject to the Release set forth in paragraph II.8 of this Agreement.
  3. Release by HHS.  In consideration of and conditioned upon Life Hope Labs’s performance of its obligations under this Agreement, HHS releases Life Hope Labs from any actions it may have against Life Hope Labs under the HIPAA Rules arising out of or related to the Covered Conduct identified in paragraph I.2 of this Agreement.  HHS does not release Life Hope Labs from, nor waive any rights, obligations, or causes of action other than those arising out of or related to the Covered Conduct and referred to in this paragraph.  This release does not extend to actions that may be brought under section 1177 of the Social Security Act, 42 U.S.C. § 1320d-6.
  4. Agreement by Released Parties.  Life Hope Labs shall not contest the validity of its obligation to pay, nor the amount of, the Resolution Amount or any other obligations agreed to under this Agreement. Life Hope Labs waives all procedural rights granted under Section 1128A of the Social Security Act (42 U.S.C. § 1320a- 7a) and 45 C.F.R. Part 160 Subpart E, and HHS claims collection regulations at 45 C.F.R. Part 30, including, but not limited to, notice, hearing, and appeal with respect to the Resolution Amount.
  5. Binding on Successors. This Agreement is binding on Life Hope Labs and its successors, heirs, transferees, and assigns.
  6. Costs.  Each Party to this Agreement shall bear its own legal and other costs incurred in connection with this matter, including the preparation and performance of this Agreement.
  7. No Additional Releases.  This Agreement is intended to be for the benefit of the Parties only and by this instrument the Parties do not release any claims against or by any other person or entity.
  8. Effect of Agreement.  This Agreement constitutes the complete agreement between the Parties.  All material representations, understandings, and promises of the Parties are contained in this Agreement.  Any modifications to this Agreement shall be set forth in writing and signed by all Parties. 
  9. Execution of Agreement and Effective Date.  The Agreement shall become effective (i.e., final and binding) upon the date of signing of this Agreement and the CAP by the last signatory (Effective Date).
  10. Tolling of Statute of Limitations. Pursuant to 42 U.S.C. § 1320a-7a(c)(1), a civil money penalty (“CMP”) must be imposed within six years from the date of the occurrence of the violation.  To ensure that this six-year period does not expire during the term of this Agreement, Life Hope Labs agrees that the time between the Effective Date of this Agreement and the date the Agreement may be terminated by reason of Life Hope Labs’s breach, plus one-year thereafter, will not be included in calculating the six (6) year statute of limitations applicable to the violations which are the subject of this Agreement.  Life Hope Labs waives and will not plead any statute of limitations, laches, or similar defenses to any administrative action relating to the Covered Conduct identified in paragraph I.2 that is filed by HHS within the time period set forth above, except to the extent that such defenses would have been available had an administrative action been filed on the Effective Date of this Agreement.
  11. Disclosure.  HHS places no restriction on the publication of the Agreement.
  12. Execution in Counterparts.  This Agreement may be executed in counterparts, each of which constitutes an original, and all of which shall constitute one and the same agreement. 
  13. Authorizations.  The individual(s) signing this Agreement on behalf of Life Hope Labs represents and warrants that they are authorized to execute this Agreement and bind Life Hope Labs, as set forth in paragraph I.1.b.  The individual(s) signing this Agreement on behalf of HHS represent and warrant that they are signing this Agreement in their official capacities and that they are authorized to execute this Agreement.

Life Hope Labs, LLC

 /S/                                                                   
Alan Brock                                                                           
Chief Executive Officer                                                                                            
Life Hope Labs, LLC

Date: 12/14/2022

 

For Department of Health and Human Services

 

/S/                                                                                    
Barbara Stampul                                                                    
Regional Manager, Southeast Region
Office for Civil Rights                                   

Date: 12/14/2022

Appendix A

Corrective Action Plan

Between the

Department of Health and Human Services

and

Life Hope Labs, LLC

 

I.          Preamble

Life Hope Labs, LLC. (“Life Hope Labs”) hereby enters into this Corrective Action Plan (“CAP”) with the United States Department of Health and Human Services, Office for Civil Rights (“HHS”). Contemporaneously with this CAP, Life Hope Labs is entering into the Agreement with HHS, and this CAP is incorporated by reference into the Agreement as Appendix A.  Life Hope Labs enters into this CAP as part of consideration for the release set forth in paragraph II.8 of the Agreement.  Capitalized terms without definition in this CAP shall have the same meaning assigned to them under the Agreement.

II.        Contact Persons and Submissions

            A.        Contact Persons

The contact person for Life Hope Labs regarding the implementation of this CAP and for receipt and submission of notifications and reports (“Life Hope Labs’s Contact”) is:

Alan Brock, Chief Executive Officer                                                            
Life Hope Labs, LLC.
5009 Roswell Rd
Sandy Springs, GA 30342
Telephone: 404-891-0121

HHS has identified the following individual as its authorized representative and contact person with whom Life Hope Labs is to report information regarding the implementation of this CAP:

Ms. Barbara Stampul, Regional Manager
Office for Civil Rights, Southeast Region
Department of Health and Human Services
61 Forsyth Street SW, Ste. 16T70
Atlanta, GA 30303
Barbara.Stampul@hhs.gov
Telephone: 404-562-2799
Facsimile:  404-562-7881

Life Hope Labs and HHS agree to promptly notify each other of any changes in the contact person or the other information provided above.

B.        Proof of Submissions.  Unless otherwise specified, all notifications and reports required by this CAP may be made by any means, including certified mail, overnight mail, electronic mail, or hand delivery, provided that there is proof that such notification was received. For purposes of this requirement, internal facsimile confirmation sheets do not constitute proof of receipt.

III.       Effective Date and Term of CAP

The Effective Date for this CAP shall be calculated in accordance with paragraph II.14 of the Agreement (“Effective Date”). The period for compliance (“Compliance Term”) with the obligations assumed by Life Hope Labs under this CAP shall begin on the Effective Date of this CAP and end two (2) years from the Effective Date, unless HHS has notified Life Hope Labs under Section IX hereof of its determination that Life Hope Labs breached this CAP.  In the event of such a notification by HHS under Section IX hereof, the Compliance Term shall not end until HHS notifies Life Hope Labs that it has determined that the breach has been cured.  After the Compliance Term ends, Life Hope Labs shall still be obligated to: (a) submit the final Annual Report as required by section VI; and (b) comply with the document retention requirement in section VII. Nothing in this CAP is intended to eliminate or modify Life Hope Labs’s obligation to comply with the document retention requirements in 45 C.F.R. §§ 164.316(b) and 164.530(j).

IV.       Time

In computing any period of time prescribed or allowed by this CAP, all days referred to shall be calendar days. The day of the act, event, or default from which the designated period of time begins to run shall not be included. The last day of the period so computed shall be included, unless it is a Saturday, a Sunday, or a legal holiday, in which event the period runs until the end of the next day which is not one of the aforementioned days.

V.        Corrective Action Obligations

Life Hope Labs agrees to the following:

A.  Policies and Procedures

1.   Life Hope Labs shall develop, maintain, and revise, as necessary, its written policies and procedures to comply with the Federal standards that govern the privacy of individually identifiable health information (45 C.F.R. Part 160 and Subparts A and E of Part 164, the “Privacy Rule”). Life Hope Labs’s policies and procedures shall address, but not be limited to, the Covered Conduct specified in paragraph I.2 of the Agreement.

2.   Life Hope Labs shall provide such policies and procedures, consistent with paragraph 1 above, to HHS within sixty (60) days of the Effective Date for review and approval.  Upon receiving any recommended changes to such policies and procedures from HHS, Life Hope Labs shall have thirty (30) days to revise such policies and procedures accordingly and provide the revised policies and procedures to HHS for review and approval.

3.   Life Hope Labs shall implement such policies and procedures within thirty (30) days of receipt of HHS’ approval.

B.  Distribution and Updating of Policies and Procedures

1.   Life Hope Labs shall distribute the policies and procedures identified in section V.A. to all members of the workforce and relevant business associates within thirty (30) days of HHS approval of such policies and to new members of the workforce within thirty (30) days of their beginning of service.

2.   Life Hope Labs shall require, at the time of distribution of such policies and procedures, a signed written or electronic initial compliance certification from all members of the workforce and relevant business associates stating that the workforce members have read, understand, and shall abide by such policies and procedures.

3.   Life Hope Labs shall assess, update, and revise, as necessary, the policies and procedures at least annually or as needed. Life Hope Labs shall provide such revised policies and procedures to HHS for review and approval. Within thirty (30) days of the effective date of any approved substantive revisions, Life Hope Labs shall distribute such revised policies and procedures to all members of its workforce and relevant business associates and shall require new compliance certifications.

C.  Minimum Content of Policies and Procedures

The Policies and Procedures shall include, but not be limited to:

1. All obligations required under 45 C.F.R. § 164.524 and all its subparts;

2. An accurate definition of a "Designated Record Set" as defined in the Privacy Rule;

3. Standardized procedures for responding to requests for access pursuant to 45 C.F.R. § 164.524;

4. Protocols for training all Life Hope Labs’s workforce members and business associates that are involved in receiving or fulfilling access requests as necessary and appropriate to ensure compliance with the policies and procedures provided for in section V.A. above;

5. Protocols for training Life Hope Labs’s workforce members that are involved in the maintaining of designated record sets and other protected health information as necessary and appropriate to ensure compliance with the policies and procedures provided for in section V.A. above; and

6. Application of appropriate sanctions against Life Hope Labs workforce members who fail to comply with policies and procedures.

D.  Training

1.   Life Hope Labs shall provide HHS with training materials per section V.C. above for all members of the workforce and relevant business associates within sixty (60) days of the approval of its policies and procedures per section V.A.

2.   Upon receiving notice from HHS specifying any required changes, Life Hope Labs shall make the required changes and provide revised training materials to HHS within thirty (30) days.

3.   Upon receiving approval from HHS, Life Hope Labs shall provide training for each workforce member and relevant business associate within sixty (60) days of HHS approval and at least every twelve (12) months thereafter.  Life Hope Labs shall also provide such training to each new member of the workforce or relevant new business associate within thirty (30) days of their beginning of service.

4.   Each workforce member and relevant business associate who is required to attend training shall certify, in electronic or written form, that he or she has received the training.  The training certification shall specify the date training was received.  All course materials shall be retained in compliance with section VII.

5.   Life Hope Labs shall review the training at least annually, and, where appropriate, update the training to reflect changes in Federal law or HHS guidance, any issues discovered during audits or reviews, and any other relevant developments.

VI.     Implementation Report and Annual Reports

A.          Implementation Report

Within 120 days after the receipt of HHS’ approval of the policies and procedures required by section V.A.1, Life Hope Labs shall submit a written report to HHS summarizing the status of its implementation of the requirements of this CAP.  This report, known as the “Implementation Report,” shall include:

1.   An attestation signed by an owner or officer of Life Hope Labs attesting that the Policies and Procedures are being implemented, have been distributed to all appropriate members of the workforce and relevant business associates and that Life Hope Labs has obtained all of the compliance certifications required by sections V.B.2. and V.B.3.;

2.   A copy of all training materials used for the training required by this CAP, a description of the training, including a summary of the topics covered, the length of the session(s) and a schedule of when the training session(s) were held;

3.   An attestation signed by an owner or officer of Life Hope Labs attesting that all members of the workforce and relevant business associates have completed the initial training required by this CAP and have executed the training certifications required by section V.D.4.;

4.   An attestation signed by an owner or officer of Life Hope Labs stating that he or she has reviewed the Implementation Report, has made a reasonable inquiry regarding its content and believes that, upon such inquiry, the information is accurate and truthful.

B.        Annual Reports

The one (1) year period after the Effective Date and each subsequent one (1) year period during the course of the Compliance Term shall be known as a “Reporting Period.”  Within sixty (60) days after the close of each corresponding Reporting Period, Life Hope Labs shall submit a report or reports to HHS regarding Life Hope Labs’s compliance with this CAP for each corresponding Reporting Period (“Annual Report”).  The Annual Report shall include:                      

1.   A copy of the schedule, topic outline, and training materials for the training programs provided during the Reporting Period that is the subject of the Annual Report;

2.   An attestation signed by an officer or director of Life Hope Labs attesting that it has obtained and maintained written or electronic training certifications from all persons who are required to attend training under this CAP;

3.   An attestation signed by an officer or director of Life Hope Labs attesting that any revision(s) to the Policies and Procedures required by section V were finalized and adopted within thirty (30) days of HHS’ approval of the revision(s), which shall include a statement affirming that Life Hope Labs distributed the revised Policies and Procedures to all appropriate members of Life Hope Labs’s workforce within sixty (60) days of HHS’ approval of the revision(s); and

4.   A summary of Reportable Events (defined in section VII), if any, the status of any corrective and preventative action(s) relating to all such Reportable Events, or an attestation signed by an officer or director of Life Hope Labs stating that no Reportable Events occurred during the Compliance Term.

5.   An attestation signed by an owner or officer of Life Hope Labs attesting that he or she has reviewed the Annual Report, has made a reasonable inquiry regarding its content and believes that, upon such inquiry, the information is accurate and truthful.

VII.     Reportable Events

A.        Reportable Events.  After the implementation of the Policies and Procedures in accordance with paragraph V.B.1, Life Hope Labs shall, during the remainder of the Compliance Term, upon receiving information that a workforce member may have failed to comply with such policies and procedures, promptly investigate the matter.  If Life Hope Labs, after review and investigation, determines that a member of its workforce has failed to comply with such policies and procedures, Life Hope Labs shall report such event(s) to HHS as provided in section VI.B.4. Such violations shall be known as “Reportable Events.” The report to HHS shall include the following:

1.  A complete description of the event, including the relevant facts, the persons involved, and the provision(s) of the Policies and Procedures implicated; and

2.  A description of the actions taken and any further steps Life Hope Labs plans to take to address the matter to mitigate any harm, and to prevent it from recurring, including application of appropriate sanctions against workforce members who failed to comply with the Policies and Procedures.

VIII.    Document Retention

Life Hope Labs shall maintain for inspection and copying, and shall provide to HHS, upon request, all documents and records relating to compliance with this CAP for six (6) years from the Effective Date.  

IX.       Breach Provisions

Life Hope Labs is expected to fully and timely comply with all provisions contained in this CAP.

A.        Timely Written Requests for Extensions.  Life Hope Labs may, in advance of any due date set forth in this CAP, submit a timely written request for an extension of time to perform any act required by this CAP.  A “timely written request” is defined as a request in writing received by HHS at least five (5) days prior to the date such an act is required or due to be performed. This requirement may be waived by HHS only.

B.        Notice of Breach of this CAP and Intent to Impose CMP.  The Parties agree that a breach of this CAP by Life Hope Labs constitutes a breach of the Agreement.  Upon a determination by HHS that Life Hope Labs has breached this CAP, HHS may notify Life Hope Labs Contact of: (1) Life Hope Labs’s breach; and (2) HHS’ intent to impose a CMP pursuant to 45 C.F.R. Part 160, for the Covered Conduct set forth in paragraph I.2 of the Agreement and any other conduct that constitutes a violation of the HIPAA Privacy, Security, or Breach Notification Rules (“Notice of Breach and Intent to Impose CMP”).

C.        Life Hope Labs’s Response.  If Life Hope Labs is named in a Notice of Breach and Intent to Impose CMP, Life Hope Labs shall have thirty (30) days from the date of receipt of the Notice of Breach and Intent to Impose CMP to demonstrate to HHS’ satisfaction that:

1. Life Hope Labs is in compliance with the obligations of the CAP that HHS cited as the basis for the breach;

2. The alleged breach has been cured; or

3. The alleged breach cannot be cured within the thirty (30) day period, but that Life Hope Labs: (a) has begun to take action to cure the breach; (b) is pursuing such action with due diligence; and (c) has provided to HHS a reasonable timetable for curing the breach.

D.        Imposition of CMP.  If at the conclusion of the thirty (30) day period, Life Hope Labs fails to meet the requirements of section IX.C. of this CAP to HHS’ satisfaction, HHS may proceed with the imposition of a CMP against Life Hope Labs pursuant to the rights and obligations set forth in 45 C.F.R. Part 160 for any violations of the HIPAA Rules applicable to the Covered Conduct set forth in paragraph I.2 of the Agreement and for any other act or failure to act that constitutes a violation of the HIPAA Rules. HHS shall notify Life Hope Labs’s Contact in writing of its determination to proceed with the imposition of a CMP pursuant to 45 C.F.R. §§ 160.312(a)(3)(i) and (ii).

For Life Hope Labs, LLC

/S/                                                                              
Alan Brock                                                                                                
Chief Executive Officer
Life Hope Labs, LLC

Date: 12/14/2022

For Department of Health and Human Services

 

/S/                                                                   
Barbara Stampul                                                              
Regional Manager, Southeast Region
Office for Civil Rights

Date: 12/14/2022

Content created by Office for Civil Rights (OCR)
Content last reviewed